the Future of Gene and Cell Therapies: A Strategic Deep Dive into Viral Vectors Manufacturing 2025-2033 The relentless march of gene and cell therapies is not merely advancing medicine; it is fundamentally reshaping the biopharmaceutical landscape. At the heart of this revolution lies viral vector manufacturing—a complex, high-technology domain pivotal to the successful delivery of life-altering genetic material. Navigating this dynamic market requires more than just…